Zeiss Meditec's First Quarter Profits Rise

By

JENA, Germany—In the first three months of fiscal year 2018/19 Carl Zeiss Meditec (ISIN: DE 0005313704) generated revenue of €323.6 million, representing an increase of 9.8 percent, or 9 percent adjusted for currency effects, compared with the same period of the previous year. Zeiss Meditec's posted significant growth was in the EMEA region, particularly in its core markets Germany, France and Southern Europe. Earnings before interest and taxes (EBIT) increased significantly to €48.1 million versus €38.9 million in the prior year. The EBIT margin also increased, to 14.9 percent compared with 13.2 percent year ago.

“We have made a successful start to the new financial year and were able to further expand our market share in both strategic business units,” explained Dr. Ludwin Monz, president and CEO of Carl Zeiss Meditec AG.

Zeiss Meditec reported that its ophthalmic devices strategic business unit (SBU) increased its revenue by 10.7 percent in the first three months of fiscal year 2018/19, an increase of 9.8 percent adjusted for currency effects, to €239.5 million, compared with €216.3 million in the same period of the prior year. This revenue increase was mainly attributable to laser vision correction systems as well as devices and consumables in cataract surgery, the company said.

Revenue in the microsurgery SBU grew by 7.4 percent, or 6.7 percent adjusted for currency effects, to €84.2 million, compared with €78.4 million in the same period of the prior year. Sales of neurosurgical visualization systems for the treatment of tumors and vascular disease also remained buoyant, Zeiss Meditec said.

Revenue in the EMEA region increased by 13.5 percent, up 15.1 percent adjusted for currency effects, to €103.5 million versus €91.2 million for the prior year. Germany, France and Southern Europe posted strong revenue growth.

In the Americas region, Zeiss posted €91.9 million in revenue versus €94.1 in the prior year, down 2.3 percent, or 4.9 percent adjusted for currency effects. Zeiss said the decrease is primarily attributable to new product launches at the beginning of the 2017/18 fiscal year, which had provided a strong boost to revenue in the same period of the prior year.

The APAC region posted a 17.1 percent revenue increase, or 16.2 percent adjusted for currency effects, to €128.2 million.